ERBB2 and breast carcinoma: The main HER2 scoring systems that are being used include guidelines for HER2 testing in breast cancer and in gastric/gastroesophageal (GE) cancer (both ASCO/CAP in the US and ESMO guidelines in Europe) and the HER2 scoring system developed for CRC in the HERACLES clinical trial (Table 1).